Companies / Benitec Biopharma Inc.

Benitec Biopharma Inc.

Nasdaq: BNTCCIK 1808898HAYWARD, CA

Financials · FY2021

Revenue$59.0K
Net income$-37.92M
Total debt
Cash$184.76M
Diluted EPS$-1.05
Shares outstanding34.4M

Ownership

34.4M shares outstanding · as of May 4, 2026
0.15%Insiders
Ownership
Insiders0.15%52,097
10%+ / strategic10.92%3,751,709
Institutions87.87%30,188,718
Public float1.05%361,810

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
0.15%52,097
Mates SharonDirector

Institutional holders 76

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$5.55M+415K
+41.80%
1,407,138
4.10% of shares
medium
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$1.78M+133K
+54.24%
377,973
1.10% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$753.4K+71K
+15.60%
524,104
1.53% of shares
low
Q1 2026
as of
Cantor Fitzgerald, L. P.
13F manager
NewCommon Stock$496.9K+47K
46,659
0.14% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
AddCommon Stock$414.3K+39K
+6.34%
652,064
1.90% of shares
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
AddCommon Stock$384.9K+36K
+101.28%
71,832
0.21% of shares
low
Q1 2026
as of
Janus Henderson Group PLC
13F manager
TrimCommon Stock$-377.1K-35K
-1.21%
2,876,380
8.37% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
NewCommon Stock$315.2K+27K
26,940
0.08% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Franklin Resources, Inc.Passive13G/A3,751,709

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BNTCCommon StockEquity08205P209BBG00R712L56